Yahoo! Finance
08-06-2008, 04:01 PM
<b>Yahoo! Finance: Commodity News</b>
GAITHERSBURG, Md.----Ore Pharmaceuticals Inc. announced today that it has acquired from Roche the exclusive development rights for the clinical-stage compound romazarit. Ore Pharmaceuticals had previously identified potentially novel therapeutic uses for romazarit in metabolic diseases and subsequently observed a lowering of lipids, weight, and glucose levels in in vivo testing.
complete story here... (http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/080806/20080806006333.html?.v=1)
GAITHERSBURG, Md.----Ore Pharmaceuticals Inc. announced today that it has acquired from Roche the exclusive development rights for the clinical-stage compound romazarit. Ore Pharmaceuticals had previously identified potentially novel therapeutic uses for romazarit in metabolic diseases and subsequently observed a lowering of lipids, weight, and glucose levels in in vivo testing.
complete story here... (http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/080806/20080806006333.html?.v=1)